Digoxin and Canasa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Canasa (mesalamine). Common drug interactions include benign cardiac neoplasm among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Canasa. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Canasa?

Canasa has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 1,676 Canasa users. Check the latest studies of Canasa.

On Aug, 09, 2026

18 people who take Digoxin and Canasa together, and have interactions are studied.

What are the common drug interactions of Digoxin and Canasa, by gender? *:

female:

Benign cardiac neoplasm (benign (non-cancerous) tumours of the heart)
Blood zinc decreased
Chest pain
Colonic polyp (extra part of colon tissue grow in intestine)
Constipation
Dehydration (dryness resulting from the removal of water)
Depression
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Diarrhoea haemorrhagic (bloody diarrhoea)
Dysgeusia (disorder of the sense of taste)

male:

Cardiac arrest
Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
Hyperkalaemia (damage to or disease of the kidney)
Multiple injuries
Hepatocellular injury (liver injury)
Polyp
Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)
Pyrexia (fever)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Ascites (accumulation of fluid in the abdominal cavity)

What are the common drug interactions of Digoxin and Canasa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cystitis escherichia (inflammation of the wall of the bladder by bacteria escherichia coli)
Dizziness
Fall
Globulins increased
Hallucination (an experience involving the perception of something not present)
Hyperhidrosis (abnormally increased sweating)
Injury
International normalised ratio increased
Lipomatous hypertrophy of the interatrial septum (non cancer fatty tissue growth within the heart partition)
Localised infection (infection at the single location)

60+:

Cardiac arrest
Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
Hyperkalaemia (damage to or disease of the kidney)
Multiple injuries
Fall
Hepatocellular injury (liver injury)
Portal hypertension (increase in the blood pressure within a system of veins called the portal venous system)
Pyrexia (fever)
Asthenia (weakness)

What are the existing conditions these people have? *

Pain: 2 people, 11.11%
High Blood Pressure: 2 people, 11.11%
Nausea (feeling of having an urge to vomit): 1 person, 5.56%
Hypersensitivity: 1 person, 5.56%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 5.56%
Blood Pressure Abnormal: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Canasa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously